What is the role of menopausal hormone replacement therapy (HRT) in the prevention of urogenital symptoms?

Updated: Sep 24, 2019
  • Author: Nicole K Banks, MD; Chief Editor: Richard Scott Lucidi, MD, FACOG  more...
  • Print


Both topical and systemic estrogens have been shown to improve the menopausal symptoms of vaginal dryness, superficial dyspareunia, and urinary frequency and urgency. Achievement of these beneficial effects require long-term therapy. Symptoms commonly recur after HT is stopped. [10]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!